In type 2 diabetes, weekly basal insulin Fc was noninferior to daily insulin degludec for HbA<sub>1c</sub> at 26 wk.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 37399561.
- Also identified by DOI 10.7326/J23-0046.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Bue-Valleskey JM, Kazda CM, Ma C, et al. <b>Once-weekly basal insulin Fc demonstrated similar glycemic control to once-daily insulin degludec in insulin-naive patients with type 2 diabetes: a phase 2 randomized control trial.</b> Diabetes Care. 2023;46:1060-1067. 36944059.
Medical subject headings
- Diabetes Mellitus, Type 2